Epizyme's (EPZM) Tazemetostat IND Submission Accepted by U.S. FDA
Tweet Send to a Friend
Epizyme, Inc. (Nasdaq: EPZM) announced that the U.S. Food and Drug Administration has accepted the company’s Investigational New Drug (IND) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE